EUR m | 12M 2022 | 12M 2021 |
Revenue | 1,771.9 | 1,627.3 |
EBITDA (adjusted) | 541.4 | 513.3 |
Exceptional items | 0.8 | -5.9 |
EBITDA | 542.2 | 507.3 |
Amortization, depreciation and impairment | -303.5 | -310.1 |
thereof attributable to purchase price allocations and impairment losses | -27.3 | -45.9 |
EBIT | 238.7 | 197.3 |
Net financial income/costs | -27.9 | -28.6 |
EBT | 210.8 | 168.7 |
Taxes | -59.0 | -38.5 |
Consolidated profit or loss for the period | 151.8 | 130.3 |
Adjusted consolidated profit or loss for the period | 171.5 | 170.2 |
Free cash flow (before M&A transactions) | 248.3 | 325.1 |
Net debt ( 31 Dec) | 718.0 | 612.3 |
1For further details on the individual financial figures, please refer to the section “Value-based management” |
In EUR m | Q3 2022 | Q3 2021 | 9M 2022 | 9M 2021 |
Revenue | 436.3 | 414.3 | 1,246.3 | 1,100.2 |
EBITDA (adjusted) | 133.6 | 138.7 | 353.9 | 318.9 |
Exceptional items | -2.7 | -2.5 | 5.4 | -5.6 |
EBITDA | 130.9 | 136.1 | 359.3 | 313.3 |
Amortization, depreciation and impairment losses | -73.3 | -75.6 | -219.6 | -231.1 |
thereof attributable to purchase price allocations and impairment losses | -6.8 | -14.6 | -20.3 | -37.5 |
EBIT | 57.6 | 60.5 | 139.7 | 82.2 |
Net finance income/costs | -5.4 | -7.4 | -17.7 | -21.5 |
EBT | 52.2 | 53.1 | 122.0 | 60.7 |
Taxes | -13.0 | -12.9 | -29.1 | -14.8 |
Consolidated profit or loss for the period | 39.1 | 40.2 | 92.9 | 45.9 |
Adjusted consolidated profit or loss for the period | 46.3 | 56.2 | 104.2 | 83.4 |
Free cash flow (before M&A transactions) | 32.2 | 76.7 | 115.9 | 159.4 |
Net debt (Sep. 30 / Dec 31.) | 739.7 | 612.3 |